Search Results

Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis.

• Authors : Hsu CK; Department of Internal Medicine, E-Da Hospital, Kaohsiung, Taiwan.; Tsai WW

Subjects: Cefepime*/Cefepime*/Cefepime*/therapeutic use ; Piperacillin*/Piperacillin*/Piperacillin*/adverse effects ; Pyelonephritis*/Pyelonephritis*/Pyelonephritis*/complications

• Source: JAMA [JAMA] 2023 Feb 28; Vol. 329 (8), pp. 684-685.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime.

• Authors : Chanderraj, Rishi; Admon, Andrew J.; He, Ying

• Source: JAMA Internal Medicine; Jul2024, Vol. 184 Issue 7, p769-777, 9p

Record details

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.

• Authors : Harris, Patrick N. A.; Tambyah, Paul A.; Lye, David C.

Subjects: PIPERACILLIN; TAZOBACTAM; MEROPENEM

• Source: JAMA: Journal of the American Medical Association. 9/11/2018, Vol. 320 Issue 10, p984-994. 11p.

Record details

Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial.

• Authors : Qian, Edward T.; Casey, Jonathan D.; Wright, Adam

Subjects: ACUTE kidney failure; CEFEPIME; KIDNEY transplantation

• Source: JAMA: Journal of the American Medical Association; 10/24/2023, Vol. 330 Issue 16, p1557-1567, 11p

Record details

Reevaluating Piperacillin-Tazobactam Mortality.

• Authors : Darlow, Christopher A.; Gerada, Alessandro; Hope, William

• Source: JAMA Internal Medicine; Oct2024, Vol. 184 Issue 10, p1267-1268, 2p

Record details

Carbapenem-Sparing Therapy for Extended-Spectrum β-Lactamase-Producing E coli and Klebsiella pneumoniae Bloodstream Infection: The Search Continues.

• Authors : Hayden, Mary K.; Won, Sarah Y.

Subjects: PIPERACILLIN; TAZOBACTAM; MEROPENEM

• Source: JAMA: Journal of the American Medical Association. 9/11/2018, Vol. 320 Issue 10, p979-981. 3p.

Record details

Reevaluating Piperacillin-Tazobactam Mortality.

• Authors : Chao, Chia-Ter

• Source: JAMA Internal Medicine; Oct2024, Vol. 184 Issue 10, p1268-1268, 1p

Record details

Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.

• Authors : D'Angelica, Michael I.; Ellis, Ryan J.; Liu, Jason B.

Subjects: ANTIBIOTIC prophylaxis; CLINICAL trials; CEFOXITINNORTH AmericaAMERICAN College of Surgeons

• Source: JAMA: Journal of the American Medical Association; 5/9/2023, Vol. 329 Issue 18, p1579-1588, 10p

Record details

Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.

• Authors : Kaye, Keith S.; Belley, Adam; Barth, Philip

Subjects: RESEARCH; PYELONEPHRITIS; CLINICAL trials

• Source: JAMA: Journal of the American Medical Association; 10/4/2022, Vol. 328 Issue 13, p1304-1314, 11p

Record details

Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial.

• Authors : Kaye, Keith S.; Bhowmick, Tanaya; Metallidis, Symeon

Subjects: DRUG resistance in bacteria; GRAM-negative bacterial diseases; URINARY tract infections

• Source: JAMA: Journal of the American Medical Association; 2/27/2018, Vol. 319 Issue 8, p788-799, 12p, 4 Charts

Record details